<DOC>
	<DOCNO>NCT00316238</DOCNO>
	<brief_summary>To investigate dose-response Rapid Acting Intramuscular Olanzapine Agitated Patients Schizophrenia</brief_summary>
	<brief_title>A Study Using Rapid Acting Intramuscular Olanzapine Agitated Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Patients must schizophrenia meet disease diagnostic criterion DSMIVTR Patients must inpatient study Patients must minimum total score le 14 five item PANSSEC least one individual item score less 4 use 17 scoring system prior first injection study drug Patients know history diabetes mellitus . Patients receive treatment antipsychotic prohibit concomitant medicine within 2 hour prior first IM study drug administration Patients treatment benzodiazepine within 4 hour prior first IM study drug administration .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>